[1]中国医院协会血液净化中心分会血管通路工作组.中国血液透析用血管通路专家共识(第2版)[J].中国血液净化,2019,18(6):365-381. DOI:10.3969/j.issn.1671-4091.2019.06.001.
[2]Kukita K, Ohira S, Amano I, et al. 2011 update Japanese Society for Dialysis Therapy Guidelines of vascular access construction and repair for chronic hemodialysis[J]. Ther Apher Dial, 2015, 19 Suppl 1:1-39. DOI: 10.1111/1744-9987.12296.
[3]KDOQI, National Kidney Foundation. KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease[J]. Am J Kidney Dis, 2006, 47(5 Suppl 3):S11-S145. DOI: 10.1053/j.ajkd.2006.03.010.
[4]Association UKR. Clinical Practice Guideline on vascular access for haemodialysis (6th Edition, Final Version) [EB/OL]. https://renal.org/wp-content/uploads/2017/06/vascular-access.pdf,2015.
[5]Polkinghorne KR, Chin GK, MacGinley RJ, et al. KHA-CARI Guideline: vascular access - central venous catheters, arteriovenous fistulae and arteriovenous grafts[J]. Nephrology (Carlton), 2013, 18(11):701-705. DOI: 10.1111/nep.12132.
[6]Foley RN, Guo H, Snyder JJ, et al. Septicemia in the United States dialysis population, 1991 to 1999[J]. J Am Soc Nephrol, 2004, 15(4):1038-1045. DOI: 10.1097/01.asn.0000119144.95922.c4.
[7]Navuluri R, Regalado S. The KDOQI 2006 vascular access update and fistula first program synopsis[J]. Semin Intervent Radiol, 2009, 26(2):122-124. DOI: 10.1055/s-0029-1222455.
[8]Ozpak B, Yilmaz Y. Arteriovenous fistulas ipsilateral to internal jugular catheters for hemodialysis have decreased patency rates[J]. Vascular, 2019, 27(3):270-276. DOI: 10.1177/1708538118811483.
[9]蒋丽琼,罗畅,吴传芳,等.1例连续性血液净化患者动静脉内瘘血肿的根因分析[J].中国当代医药,2023,30(3):185-188. DOI:10.3969/j.issn.1674-4721.2023.03.048.
[10]Lok CE, Huber TS, Lee T, et al. KDOQI clinical practice guideline for vascular access: 2019 update[J]. Am J Kidney Dis, 2020, 75(4 Suppl 2):S1-S164. DOI: 10.1053/j.ajkd.2019.12.001.
[11]刘胜利,李文秀,温玉,等.两种湿敷方法在血透患者动静脉内瘘应用的体会[J].医学信息,2013(20):412-413. DOI:10.3969/j.issn.1006-1959.2013.20.563.
[12]朱朝军,韩炜,吕佳康,等.中医外科外用药剂型特点及剂型创新的思考[J].中国临床药理学杂志,2018,34(14):1728-1731. DOI:10.13699/j.cnki.1001-6821.2018.14.040.
[13]朱鸿丽.硫酸镁液在尿毒症患者内瘘和静脉肿胀后的应用[J].吉林医学,2011,32(32):6816-6817. DOI:10.3969/j.issn.1004-0412.2011.32.041.
[14]张镜.自制银丹膏外敷治疗输液性静脉炎[J].护理学杂志,2009,24(19):23-24. DOI:10.3870/hlxzz.2009.19.023.
[15]蔡素因,谢春艳,叶琳旬,等.冷敷加新鲜马铃薯片外敷治疗血液透析自体动静脉内瘘血肿疗效观察[J].白求恩军医学院学报,2013,11(6):516-517. DOI:10.16485/j.issn.2095-7858.2013.06.011.
[16]刘丽,矫健梅,安丽伟.马铃薯切片外敷治疗动静脉内瘘并发症效果观察[J].护理学杂志,2009,24(15):14-15. DOI:10.3870/hlxzz.2009.15.014.
[17]叶锡兰,邱碧辉,夏运风,等.木瓜酒保护动静脉内瘘效果观察[J].护理学杂志,2010,25(9):12-14. DOI:10.3870/hlxzz.2010.09.012.
[18]杨淑莹,吴国锋.木瓜酶促进大鼠血管内皮细胞成血管的功能研究[J].国际医药卫生导报,2022,28(16):2276-2278. DOI:10.3760/cma.j.issn.1007-1245.2022.16.013.
[19]尔梦娜,张美丽,丁帆.在血液透析患者动静脉内瘘护理中联合应用喜疗妥的效果分析[J].中外医疗,2024,43(18):169-172. DOI:10.16662/j.cnki.1674-0742.2024.18.169.
[20]胡春燕,李雅婧,耿同会,等.HITH-4远红外线治疗仪联合多磺酸粘多糖乳膏对糖尿病血液透析患者动静脉内瘘功能的保护效果研究[J].中国全科医学,2023,26(8):951-954. DOI:10.12114/j.issn.1007-9572.2022.0550.
|